India must turn Western companies away and close the outsourcing door forever
Ritu Parna Bose
Sep. 30, 2006

India must turn Western companies away and close the outsourcing door forever. Money cannot buy India - India is not as cheap as the Western world thinks.

India has diverted most of its talents to IT and phone call making and receiving through call centers. Some greedy Indian oligarchs are exploiting Indian youth to make some money from the Western companies that come to India in search for cheap “cyber coolies and phone operators.” India’s strategic talent has been diverted towards total useless things like legacy computer programming and phone call operations. When you multiply dollar with 46, yes it is a lot of rupees and some of that is what Indian youth are getting as India plunges into slave status.

India should have learnt the trauma of British rule for more than 200 years. India was literally stripped all her wealth and made a slave country by the British. Today the same is happening “intellectually”.

It is unfortunate that Indian politicians in the name of democracy serves a handful families – the oligarch that control India. It is a shame that these oligarchs are greedy for money and have little regard for the mother India.

India faces economic challenges from the West, strategic geopolitical challenges from China and violent as well as disruptive ''terror'' challenge from Pakistan and Bangladesh. The situation for Mother India is not that great. India as a country is united within diversity. The outsourcing gimmick has to come to an end. India should refuse these Western companies from buying Indian talents cheap.

India must turn Western companies away and close the outsourcing door forever
Ritu Parna Bose
Money cannot buy India - India is not as cheap as the Western world thinks.
READ MORE>>

GlaxoSmithKline victory sets forth a new precedence of making drugs in India and China and shipping the same to US and Western Europe
Babu Ghanta
It shows that GlaxoSmithKline may have set a precedence that can allow outsourcing of drugs and marketing the same in US and Europe.
READ MORE>>

National Health Service in UK suffers a setback as Accenture quits $3.7 billion contract
Preeti Singhani
iSoft now will transfer the work to Computer Science Corporation.
READ MORE>>

Gilead Announces Licensing Agreements with Eight India-Based Companies for Manufacturing and Distribution of Generic Versions Of Viread in the Developing World
Media Release
The license agreements require that the generic companies meet certain national and international regulatory standards and include a technology transfer to enable expeditious production of large volumes of high-quality generic versions of tenofovir DF.
READ MORE>>

India's biggest drugmaker Ranbaxy Laboratories in pact with US-based Gilead for 'Tenofovir'
Media Release
While the API would be made available to other Gilead licensees in India, TDF formulations could be marketed in 95 developing countries including India, Ranbaxy informed the Bombay Stock Exchange.
READ MORE>>

MORE ARTICLES >>